These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33537575)

  • 1. Counselling for smoking cessation during pregnancy reduces tobacco-specific nitrosamine (NNAL) concentrations: A randomized controlled trial.
    Loukopoulou AN; Vardavas CI; Farmakides G; Rosolymos C; Chrelias C; Tzatzarakis M; Tsatsakis A; Myridakis A; Lyberi M; Behrakis PK
    Eur J Midwifery; 2018; 2():14. PubMed ID: 33537575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal Exposure to Carcinogens With Tobacco Use in Pregnancy: Phase 1 MAW Study Findings.
    Flanagan CA; Koller KR; Wolfe AW; Thomas TK; Benowitz NL; Renner CC; Hughes C; Hatsukami DK; Bronars C; Murphy NJ; Day G; Decker PA; Patten CA
    Nicotine Tob Res; 2016 Nov; 18(11):2162-2168. PubMed ID: 27190400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
    Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
    J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
    Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
    Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of 4-(methylnirosamino) -4-(3-pyridyl)-1-butanol (NNA) in urine of pregnant women by means of LC/MS/MS].
    Florek E; Piekoszewski W; Lechowicz W; Szymańska A; Kornacka MK
    Przegl Lek; 2006; 63(10):926-31. PubMed ID: 17288186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
    Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
    Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
    Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and study protocol of the maternal smoking cessation during pregnancy study, (M-SCOPE).
    Loukopoulou AN; Vardavas CI; Farmakides G; Rossolymos C; Chrelias C; Tzatzarakis MN; Tsatsakis A; Lymberi M; Connolly GN; Behrakis PK
    BMC Public Health; 2011 Dec; 11():903. PubMed ID: 22145828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
    Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
    J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When smokers quit: exposure to nicotine and carcinogens persists from thirdhand smoke pollution.
    Matt GE; Quintana PJE; Zakarian JM; Hoh E; Hovell MF; Mahabee-Gittens M; Watanabe K; Datuin K; Vue C; Chatfield DA
    Tob Control; 2016 Sep; 26(5):548-556. PubMed ID: 27655249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
    Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
    J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.
    Ellerbeck EF; Nollen N; Hutcheson TD; Phadnis M; Fitzgerald SA; Vacek J; Sharpe MR; Salzman GA; Richter KP
    JAMA Netw Open; 2018 Sep; 1(5):e181843. PubMed ID: 30646142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites of a tobacco-specific carcinogen in urine from newborns.
    Lackmann GM; Salzberger U; Töllner U; Chen M; Carmella SG; Hecht SS
    J Natl Cancer Inst; 1999 Mar; 91(5):459-65. PubMed ID: 10070946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
    Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
    J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking Exposure in Early Pregnancy and Adverse Pregnancy Outcomes: Usefulness of Urinary Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Levels.
    Lee SW; Han YJ; Cho DH; Kwak HS; Ko K; Park MH; Han JY
    Gynecol Obstet Invest; 2018; 83(4):365-374. PubMed ID: 29739005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The London Exercise And Pregnant smokers (LEAP) trial: a randomised controlled trial of physical activity for smoking cessation in pregnancy with an economic evaluation.
    Ussher M; Lewis S; Aveyard P; Manyonda I; West R; Lewis B; Marcus B; Riaz M; Taylor AH; Barton P; Daley A; Essex H; Esliger D; Coleman T
    Health Technol Assess; 2015 Oct; 19(84):vii-xxiv, 1-135. PubMed ID: 26491878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tobacco-specific carcinogen in the fetus.
    Milunsky A; Carmella SG; Ye M; Hecht SS
    Prenat Diagn; 2000 Apr; 20(4):307-10. PubMed ID: 10740203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.